Description
A potent CCK2/gastrin receptor antagonist that exhibits selective binding for CCK2 compared to CCK1; exhibits synergistic inhibitory effects on the cell viability of human gastric cancer cells when administered in combination with the selective COX-2 inhibitor NS-398